These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6710339)

  • 21. Tissue PO2 during reanimation with hemoglobin solutions.
    Messmer K; Jesch F; Endrich B; Hobbhahn J; Peters W; Schoenberg M
    Eur Surg Res; 1979; 11(3):161-71. PubMed ID: 510325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal accumulation of infused stroma-free hemoglobin. Potential toxicity of an oxygen-carrying substitute.
    Velky TS; Lee ES; Maffuid PW; Robinson GT; Yang JC; Greenburg AG
    Arch Surg; 1987 Mar; 122(3):355-7. PubMed ID: 3827578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of human polymerized hemoglobin as a blood substitute after acute trauma and urgent surgery.
    Gould SA; Moore EE; Moore FA; Haenel JB; Burch JM; Sehgal H; Sehgal L; DeWoskin R; Moss GS
    J Trauma; 1997 Aug; 43(2):325-31; discussion 331-2. PubMed ID: 9291380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Massive exchange transfusions with crystalline hemoglobin solution and subsequent replacement of hemoglobin and blood volume.
    DeVenuto F; Friedman HI; Mellick PW
    Surg Gynecol Obstet; 1980 Sep; 151(3):361-5. PubMed ID: 7404303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of hemoglobin solutions in kidney perfusions.
    Daniels FH; McCabe RE; Leonard EF
    Crit Rev Biomed Eng; 1984; 9(4):315-45. PubMed ID: 6423345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamics and oxygen transport after partial and total blood exchange with pyridoxalated polyhemoglobin in dogs.
    Hobbhahn J; Vogel H; Kothe N; Brendel W; Peter K; Jesch F
    Acta Anaesthesiol Scand; 1985 Jul; 29(5):537-43. PubMed ID: 4036540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans.
    Hughes GS; Yancey EP; Albrecht R; Locker PK; Francom SF; Orringer EP; Antal EJ; Jacobs EE
    Clin Pharmacol Ther; 1995 Oct; 58(4):434-43. PubMed ID: 7586936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphologic effects following massive exchange transfusions with a stroma-free hemoglobin solution. I. Liver.
    Friedman HI; DeVenuto F; Lollini L; Mellick P; Zuck TF
    Lab Invest; 1978 Aug; 39(2):167-77. PubMed ID: 682601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical development of human polymerized hemoglobin as a blood substitute.
    Gould SA; Moss GS
    World J Surg; 1996; 20(9):1200-7. PubMed ID: 8864082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive properties of synthetic blood substitutes.
    de Figueiredo LF
    Medicina (B Aires); 1998; 58(4):403-10. PubMed ID: 9816703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biophysical characteristics of hemoglobin intramolecularly cross-linked and polymerized.
    Berbers GA; Bleeker WK; Stekkinger P; Agterberg J; Rigter G; Bakker JC
    J Lab Clin Med; 1991 Feb; 117(2):157-65. PubMed ID: 1993858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histology and ultrastructure of liver and kidney following blood exchange with ultrapurified, polymerised bovine hemoglobin in comparison with hydroxyethyl starch.
    Lipfert B; Standl T; Düllmann J; Helmchen U; Schulte am Esch J; Lorke DE
    Lab Invest; 1999 May; 79(5):573-82. PubMed ID: 10334568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement.
    Vlahakes GJ; Lee R; Jacobs EE; LaRaia PJ; Austen WG
    J Thorac Cardiovasc Surg; 1990 Sep; 100(3):379-88. PubMed ID: 2391974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Resuscitation with stroma-free hemoglobin solution after acute blood loss].
    Endrich B; Jesch F; Peters W; Messmer K
    Langenbecks Arch Chir; 1976; Suppl():53-7. PubMed ID: 1031829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemoglobin solution--from tetramer to polymer.
    Moss GS; Gould SA; Sehgal LR; Sehgal HL; Rosen AL
    Prog Clin Biol Res; 1984; 165():191-210. PubMed ID: 6390452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyridoxylated polymerized hemoglobin solution processing. Interest of a membrane molecular fractionation step.
    Clerc Y; Dubos M; Bihoreau N; Delamourd L; Brasseur C; Gond B; Goyffon M; Saint-Blancard J
    Appl Biochem Biotechnol; 1987 Apr; 14(3):241-51. PubMed ID: 3631953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gas exchange and hemodynamics following complete replacement of blood with a solution of purified hemoglobin].
    Fedorov NA; Iarochkin VS; Koziner VB
    Biull Eksp Biol Med; 1977 Oct; 84(10):402-5. PubMed ID: 912051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biophysical properties of resuscitation fluids.
    Cerny LC; Stasiw DM; Cerny EL
    Crit Care Med; 1982 Apr; 10(4):254-60. PubMed ID: 7067475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of oxygen-carrying resuscitation fluids with morphine.
    Kemner JM; Snodgrass WR; Worley SE; Hodges GR; Clark GM; Hignite CE
    J Lab Clin Med; 1984 Sep; 104(3):433-44. PubMed ID: 6470567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary constrictor effect of stroma-free hemoglobin solutions.
    Vogel WM; Dennis RC; Cassidy G; Apstein CS; Valeri CR
    Am J Physiol; 1986 Aug; 251(2 Pt 2):H413-20. PubMed ID: 3740293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.